Literature DB >> 11382555

Critical effect sizes in toxicological risk assessment: a comprehensive and critical evaluation.

S Dekkers1, C de Heer, M A.J. Rennen.   

Abstract

A key issue in toxicological risk assessment is determining the effect level below which there is no reason for concern. In the Benchmark approach, this breaking point between adverse and non-adverse is called the critical effect size (CES). This study aimed to investigate the possibilities to determine CESs for toxicological effect parameters commonly used in human risk assessment and includes a literature review and an opinion analysis among European toxicologists. The results indicate that the current knowledge is insufficient to define CESs for all individual parameters. Furthermore, the use of a single universal CES seems no option. It is concluded that it is not yet possible to reach international consensus on CESs for most toxicological parameters. However, every parameter for which consensus on the CES is reached is a step forward, because this can facilitate discussions on the adversity and relevance of certain changes in that parameter, irrespective of the method applied in risk assessment.

Entities:  

Year:  2001        PMID: 11382555     DOI: 10.1016/s1382-6689(01)00068-0

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  2 in total

1.  Use of benchmark dose models in risk assessment for occupational handlers of eight pesticides used in pome fruit production.

Authors:  Jane Gurnick Pouzou; John Kissel; Michael G Yost; Richard A Fenske; Alison C Cullen
Journal:  Regul Toxicol Pharmacol       Date:  2019-10-23       Impact factor: 3.271

2.  Low-level lead exposure and elevations in blood pressure during pregnancy.

Authors:  Ellen M Wells; Ana Navas-Acien; Julie B Herbstman; Benjamin J Apelberg; Ellen K Silbergeld; Kathleen L Caldwell; Robert L Jones; Rolf U Halden; Frank R Witter; Lynn R Goldman
Journal:  Environ Health Perspect       Date:  2011-02-02       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.